Immunoregulatory Bacterial Factors in Ulcerative Colitis

James, Stephen P.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• Type: Research Project (R01)
• Project #: 5R01DK047708-04
• Application #: 2016786
• Study Section: Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
• Project Start: 1993-09-30
• Project End: 1997-08-31
• Budget Start: 1996-09-23
• Budget End: 1997-08-31
• Support Year: 4
• Fiscal Year: 1996

Institution

• Name: University of Maryland Baltimore
• Department: Internal Medicine/Medicine
• Type: Schools of Medicine
• DUNS #: 003255213
• City: Baltimore
• State: MD
• Country: United States
• Zip Code: 21201

Publications

Klapproth, J M; Scaletsky, I C; McNamara, B P et al. (2000) A large toxin from pathogenic Escherichia coli strains that inhibits lymphocyte activation. Infect Immun 68:2148-55

Malstrom, C; James, S (1998) Inhibition of murine splenic and mucosal lymphocyte function by enteric bacterial products. Infect Immun 66:3120-7

Langford, C A; Klippel, J H; Balow, J E et al. (1998) Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease. Part 2: Inflammatory bowel disease, systemic vasculitis, and therapeutic toxicity. Ann Intern Med 129:49-58

Darwin, P E; Sztein, M B; Zheng, Q X et al. (1996) Immune evasion by Helicobacter pylori: gastric spiral bacteria lack surface immunoglobulin deposition and reactivity with homologous antibodies. Helicobacter 1:20-7

Klapproth, J M; Donnenberg, M S; Abraham, J M et al. (1996) Products of enteropathogenic E. coli inhibit lymphokine production by gastrointestinal lymphocytes. Am J Physiol 271:G841-8

Klapproth, J M; Donnenberg, M S; Abraham, J M et al. (1995) Products of enteropathogenic Escherichia coli inhibit lymphocyte activation and lymphokine production. Infect Immun 63:2248-54